metastatic prostate cancer

https://cris.fau.de/publications/231423338/?lang=de_DE 99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and... metastatic prostate cancer for patients mip spect https://ecancer.org/en/news/1680-aacr-2011-scientists-identify-kras-rearrangements-in-metastatic-prostate-cancer AACR 2011: Scientists identify KRAS rearrangements in metastatic prostate cancer - ecancer Scientists have uncovered a genetic characteristic of metastatic prostate cancer that defines a rare sub-type of this disease. These findings are published in C metastatic prostate cancer aacr scientists identify kras https://pubmed.ncbi.nlm.nih.gov/21612468/ Abiraterone and increased survival in metastatic prostate cancer The inhibition of androgen biosynthesis by abiraterone acetate prolonged overall survival among patients with metastatic castration-resistant prostate cancer... metastatic prostate cancer abiraterone increased survival https://nyulangone.org/news/survivornet-advances-metastatic-prostate-cancer SurvivorNet: Advances in Metastatic Prostate Cancer | NYU Langone News NYU Langone expert Dr. David R. Wise explains the latest advances in treating metastatic prostate cancer. Learn more. metastatic prostate cancer advances nyu news https://intbrazjurol.com.br/difference-of-opinion/radical-prostatectomy-in-metastatic-prostate-cancer-is-there-enough-evidence-2/ Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes |... metastatic prostate cancer radical prostatectomy enough evidence opinion https://www.phil.muni.cz/en/research/publishing-and-editorial-activities-of-the-faculty/overview-of-publishing-and-scientific-activities/1334095 Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating | Faculty of Arts... metastatic prostate cancer faculty of arts oxidative stress resistance renewal https://iro.uiowa.edu/esploro/outputs/abstract/Cardiovascular-toxicity-with-androgen-receptor-pathway-inhibitors/9985142056702771?institution=01IOWA_INST&skipUsageReporting=true&recordUsage=false Cardiovascular toxicity with androgen-receptor pathway inhibitors in metastatic prostate cancer: A... 145 Background: Multiple trials have demonstrated addition of androgen-receptor pathway inhibitors (ARPIs) improve survival in patients with metastatic... metastatic prostate cancer androgen receptor cardiovascular toxicity pathway https://www.scilifelab.se/news/precision-medicine-diagnostic-test-for-metastatic-prostate-cancer-transitions-from-research-to-application/ Precision medicine: diagnostic test for metastatic prostate cancer transitions from research to... Jun 28, 2023 - Karolinska University Hospital in Sweden now offers routine diagnostic testing of cell-free DNA in patients with metastatic prostate cancer. Researchers at... metastatic prostate cancer precision medicine diagnostic test transitions research https://portal.fis.tum.de/en/publications/the-value-of-tumor-markers-in-men-with-metastatic-prostate-cancer/ The value of tumor markers in men with metastatic prostate cancer undergoing [177Lu]Lu-PSMA... metastatic prostate cancer the value tumor markers in men psma https://fair.unifg.it/handle/11369/468399 Personalized medicine for metastatic prostate cancer: The paradigm of PARP inhibitors metastatic prostate cancer personalized medicine the paradigm parp inhibitors https://boris-portal.unibe.ch/entities/publication/69453632-9258-46b6-881b-333826e76b53 Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a... Background Metformin is a widely used anti-diabetic drug. Several studies have suggested that metformin has anticancer activity in some malignancies, including... metastatic prostate cancer for patients metformin starting androgen https://curie.fr/publications/integrative-identification-non-coding-regulatory-regions-driving-metastatic-prostate-cancer Integrative identification of non-coding regulatory regions driving metastatic prostate cancer -... Retrouvez Integrative identification of non-coding regulatory regions driving metastatic prostate cancer. L'Institut Curie est le 1er centre de recherche et de... metastatic prostate cancer integrative identification non coding https://avesis.akdeniz.edu.tr/yayin/77b6ee81-90db-4e99-997c-48112c8cc9a2/line-of-abiraterone-acetate-in-castration-resistant-metastatic-prostate-cancer-does-it-matter-report-of-a-multi-institutional-experience Line of abiraterone acetate in castration-resistant metastatic prostate cancer - Does it matter?... metastatic prostate cancer does it matter abiraterone acetate line castration https://www.sflorg.com/2024/03/med03182402.html Scientific Frontline: Attacking metastatic prostate cancer early with combination treatment... early all men who are diagnosed with metastatic hormone-sensitive prostate cancer are treated with androgen deprivation therapy metastatic prostate cancer scientific frontline attacking early https://ascopost.com/issues/november-10-2018/radiation-to-primary-tumor-in-metastatic-prostate-cancer/ Radiation to Primary Tumor in Metastatic Prostate Cancer - The ASCO Post metastatic prostate cancer radiation primary tumor asco https://cme.utsouthwestern.edu/109-051420 109 Combined Modality Conference: "Metastatic Prostate Cancer " (051420) | UT Southwestern metastatic prostate cancer ut southwestern combined modality conference https://exactitudeconsultancy.com/reports/70875/non-metastatic-prostate-cancer-nmpc-market Non-metastatic Prostate Cancer nmPC Market Analysis 2024 The Non-Metastatic Prostate Cancer Market Is Set To Grow At An Estimated CAGR Of 5.5% From 2025 To 2034, Rising From $7.5 Billion In 2024 To $12.8 Billion By... metastatic prostate cancer market analysis non nmpc https://research.regionh.dk/en/publications/udredning-og-behandling-af-osteoporose-hos-patienter-med-prostata/fingerprints/ [Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer] -... prevention and treatment metastatic prostate cancer osteoporosis non https://news.ki.se/precision-therapy-for-metastatic-prostate-cancer-improves-survival Precision therapy for metastatic prostate cancer improves survival | Karolinska Institutet Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment... metastatic prostate cancer karolinska institutet precision therapy improves https://ctv.veeva.com/study/carboplatin-everolimus-and-prednisone-in-treating-patients-with-metastatic-prostate-cancer-that-pr Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That... RATIONALE: Drugs used in chemotherapy, such as carboplatin and prednisone, work in different ways to stop the growth of tumor cells, either by killing the... metastatic prostate cancer everolimus prednisone treating patients https://medical-data-models.org/18125 Eligibility Metastatic Prostate Cancer NCT00494338 - Portal of Medical Data Models (MDM-Portal) Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00494338 metastatic prostate cancer medical data eligibility portal models https://repository.icr.ac.uk/items/c9c3821f-da7f-4ccc-aee4-d7cd5bbc5885 DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. BACKGROUND: Prostate cancer is a heterogeneous disease, but current treatments are not based on molecular stratification. We hypothesized that metastatic,... metastatic prostate cancer dna repair defects olaparib https://unifind.unisr.it/resource/item/17312?language=en-US UniSR - UNIFIND - Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts... Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and... metastatic prostate cancer current concepts treatment primary tumor https://edrn.cancer.gov/data-and-resources/publications/36264673-metastatic-prostate-cancer-diagnosed-by-fine-needle-aspiration-contemporary-cytopathologic-and-biomarker-assessment-with-clinical-correlates/ Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and... This is a publication by a member of the Early Detection Research Network. metastatic prostate cancer diagnosed fine needle aspiration https://www.pcf.org/research-conversations-better-treatments/ Research Conversations: Better Treatments for Metastatic Prostate Cancer | Prostate Cancer... Oct 7, 2025 - Medical oncologist and PCF-funded Young Investigator Dr. Martin Schoen discusses a recent publication supported by his 2022 Young Investigator Award.... metastatic prostate cancer research conversations better treatments https://www.techscience.com/CJU/v22n2/61291 CJU | Large cell differentiation of metastatic prostate cancer after androgen deprivation therapy We present a case of a 75-year-old male with a history of high risk prostate cancer who underwent androgen deprivation therapy and palliative radiation... metastatic prostate cancer cell differentiation cju large androgen https://synapse.patsnap.com/blog/fusion-pharmaceuticals-initiates-phase-2-alphabreak-trial-of-fpi-2265-in-metastatic-prostate-cancer Fusion Pharmaceuticals Initiates Phase 2 AlphaBreak Trial of FPI-2265 in Metastatic Prostate Cancer Fusion Pharmaceuticals revealed that the initial participant has received a dose in the AlphaBreak Trial's Phase 2 study of FPI-2265 for treating metastatic... metastatic prostate cancer fusion pharmaceuticals phase trial https://researchportal.tuni.fi/fi/publications/copy-number-analysis-indicates-monoclonal-origin-of-lethal-metast-2/ Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer - Tampereen... metastatic prostate cancer number analysis origin of copy indicates https://www.a-1homecare.com/clinical-trials-on-metastatic-prostate-cancer/ Clinical Trials on Metastatic Prostate Cancer - A1 Home Care Agency Sep 1, 2025 - It is important to understand that it is very crucial that cancer patients participate in clinical trials to advance the research. metastatic prostate cancer home care agency clinical trials https://publicatt.unicatt.it/handle/10807/303651 Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel... quality of life metastatic prostate cancer in patients following treatment https://www.cancerresearchuk.org/about-cancer/prostate-cancer/metastatic-cancer/treatment/treating-symptoms Treating symptoms of metastatic prostate cancer | Cancer Research UK Symptoms of metastatic or advanced prostate cancer include bone pain, problems passing urine and tiredness. Doctors and nurses can support you and give... metastatic prostate cancer treating symptoms research uk https://www.survivornet.com/guide/navigating-the-path-forward-a-guide-for-veterans-facing-metastatic-prostate-cancer/ Navigating the Path Forward: A Guide for Veterans Facing Metastatic Prostate Cancer - SurvivorNet the path forward metastatic prostate cancer navigating guide veterans https://www.uchicagomedicine.org/cancer/types-treatments/prostate-cancer/treatment/metastatic-prostate-cancer Metastatic Prostate Cancer Treatment - UChicago Medicine The prostate cancer team at the University of Chicago Medicine specializes in the latest techniques for the treatment of metastatic prostate cancer. metastatic prostate cancer uchicago medicine treatment https://www.knowcancer.com/cancer-trials/NCT00589420/ Sorafenib and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond... RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as doce metastatic prostate cancer did not treating patients respond https://malecare.org/radium-223-alpharadin-improves-survival-in-men-with-metastatic-prostate-cancer/ Radium-223 (Alpharedin) Improves Survival in Men with Metastatic Prostate Cancer - malecare.org Oct 19, 2017 - At the October 28 meeting of the American Society for Radiation the final data from the ALSYMPCA trial were presented. The trial evaluated radium-223 metastatic prostate cancer in men radium improves survival https://www.mayo.edu/research/clinical-trials/cls-20111956 S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer - Mayo Clinic Learn more about services at Mayo Clinic. metastatic prostate cancer phase iii mayo clinic adt tak https://www.epistemonikos.org/en/documents/09ed4e83563455fc89c27ebc918b5d402f76d377 Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer This is a randomized, double blind, multi-institutional phase II therapeutic study of Indoximod or placebo after the completion of standard of care sipuleuce... metastatic prostate cancer phase ii for patients study refractory https://medicalupdateonline.com/tag/metastatic-prostate-cancer/ metastatic prostate cancer Archives - Medical Update Online metastatic prostate cancer medical update archives online https://pure.psu.edu/en/publications/investigating-the-usage-of-abiraterone-in-african-american-men-wi/ Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer -... metastatic prostate cancer african american investigating usage abiraterone https://repub.eur.nl/pub/125903 RePub, Erasmus University Repository: Cabazitaxel in Metastatic Prostate Cancer. Reply metastatic prostate cancer erasmus university repository reply https://researchportalplus.anu.edu.au/en/publications/radiotherapy-to-the-primary-tumour-for-newly-diagnosed-metastatic/fingerprints/?sortBy=alphabetically Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a... for newly diagnosed metastatic prostate cancer to the radiotherapy primary https://research.knu.ac.kr/en/publications/comparative-proteome-profiling-and-mutant-protein-identification-/ Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer... metastatic prostate cancer protein identification comparative proteome profiling https://outcomes4me.com/metastatic-prostate-cancer-survival-rate/ Understanding Metastatic Prostate Cancer Survival Rates Dec 21, 2025 - Get clear answers about the metastatic prostate cancer survival rate, what affects your outlook, and how treatment and lifestyle choices can make a difference. metastatic prostate cancer survival rates understanding https://economictimes.indiatimes.com/topic/metastatic-prostate-cancer metastatic prostate cancer: Latest News & Videos, Photos about metastatic prostate cancer | The... metastatic prostate cancer Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. metastatic prostate cancer Blogs, Comments and... metastatic prostate cancer latest news videos photos https://www.irst.emr.it/it/pubblicazioni/testing-brca-12-mutations-in-metastatic-prostate-cancer-results-of-a-survey-of-the-italian-association-of-medical-oncology Testing BRCA 12 Mutations in Metastatic Prostate Cancer Results of a Survey of the Italian... Clinical genitourinary cancer metastatic prostate cancer results of testing brca mutations https://elderlytimes.com/health-and-wellness/treatment-by-metastatic-prostate-cancer-drug/ Treatment By Metastatic Prostate Cancer Drug - ElderlyTimes.com Nov 2, 2023 - Metastatic prostate cancer is a form of cancer which can outspread to other parts of human body. Metastatic prostate cancer is a progressive kind of cancer. metastatic prostate cancer treatment drug https://www.meetaugust.ai/en/blog/metastatic-prostate-cancer-treatment-options-and-symptom-management Navigating Metastatic Prostate Cancer: A Compassionate Guide to Your Treatment and Care Learn about Metastatic Prostate Cancer: Treatment Options and Symptom Management, including symptoms, causes, and when to seek care. metastatic prostate cancer treatment and care guide to navigating compassionate https://art.torvergata.it/handle/2108/322380 ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer metastatic prostate cancer novel biomarker https://www.thebusinessresearchcompany.com/report/metastatic-prostate-cancer-global-market-report Metastatic Prostate Cancer Market Size, Share Growth Report 2026 The global Metastatic Prostate Cancer market size is expected to reach $13.16 billion by 2030 at 8.3% CAGR, driven by the rising demand for personalized... metastatic prostate cancer market size growth report share https://medically.roche.com/ca/en/oncology/diseases/materials/esmo-2021-video-huddart-02.html Support for abiraterone plus ADT plus docetaxel in metastatic prostate cancer metastatic prostate cancer support for abiraterone plus adt https://www.nyp.org/healthlibrary/definitions/metastatic-prostate-cancer Metastatic Prostate Cancer - Health Library | NewYork-Presbyterian Metastatic prostate cancer is prostate cancer that has spread (metastasized) to the lymph nodes or other parts of the body. Prostate cancer is the abnormal... metastatic prostate cancer health library newyork presbyterian https://www.spandidos-publications.com/10.3892/mco.2016.825/abstract Metastatic prostate cancer initially presenting as chylothorax: A case report International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis. metastatic prostate cancer case report presenting chylothorax https://adisinsight.springer.com/trials/700244539?error=cookies_not_supported&code=905a8053-e5c8-43bd-8396-9dcfaa1ffd68 A Phase I/IIA Study of PET Imaging With 89Zr-Df-IAb2M in Patients With Metastatic Prostate Cancer -... This phase I/IIa study is evaluating the safety and feasibility of [89Zr]Df-IAB2M as an immunoPET tracer for metastatic prostate cancer. metastatic prostate cancer pet imaging phase iia study https://oncohemakey.com/prevalence-and-management-of-castration-resistant-prostate-cancer-of-unknown-metastatic-status-in-the-real-world-setting-the-afrodita-study/ Prevalence and management of castration-resistant prostate cancer of unknown metastatic status in... prostate cancer prevalence management castration resistant https://www.ispor.org/vih-articles/Volume-18--Issue-3/Health-Related-Quality-Of-Life-In-Metastatic-Castration-Resistant-Prostate-Cancer--A-Critical-Literature-Review Health-Related Quality Of Life In Metastatic Castration-Resistant Prostate Cancer- A Critical... quality of life health related prostate cancer metastatic castration https://www.pfizerclinicaltrials.com/find-a-trial/nct06629779-metastatic-castration-resistant-prostate-cancer-trial Clinical Trial for Metastatic Castration-Resistant Prostate Cancer. | Pfizer View information on a Metastatic Castration-Resistant Prostate Cancer clinical trial: Pfizer study NCT06629779. See if you may be eligible. clinical trial prostate cancer metastatic castration resistant

Robuta